Publications by authors named "H Bindu Lingam"

Article Synopsis
  • The FDA has approved elacestrant for treating postmenopausal women and adult men with advanced or metastatic ER+ and HER2- breast cancer, specifically for those who have disease progression after endocrine therapy.
  • The approval was based on the EMERALD trial, which involved 478 patients and showed significant improvement in progression-free survival (PFS) for those with mutations in estrogen receptor 1 (ER1).
  • While no overall survival benefit was conclusively demonstrated, the results were favorable for the mutation subgroup, though patients taking elacestrant experienced more side effects like nausea and dyslipidemia.
View Article and Find Full Text PDF

Introduction: Oral cancer is a multistep process involving enhanced activation of proto-oncogenes. Survivin (anti-apoptotic protein) is one of such proto-oncogenes that contribute to the carcinogenesis by deregulating cell proliferation. Expression of these proteins in cancerous and pre-cancerous lesions helps a better understanding of the etiology, treatment and prognosis.

View Article and Find Full Text PDF

Acute traumatic spinal cord injury (SCI) can result in severe, lifelong neurological deficits. After SCI, Rho activation contributes to collapse of axonal growth cones, failure of axonal regeneration, and neuronal loss. This randomized, double-blind, placebo-controlled phase 2b/3 study evaluated the efficacy and safety of Rho inhibitor VX-210 (9 mg) in patients after acute traumatic cervical SCI.

View Article and Find Full Text PDF

Purpose Of Review: Clinical video teleconferencing (CVT) represents a robust mechanism for more accessible medical care. Providers who practice medicine via CVT, including teleprescribing, should understand a number of core practical and regulatory factors. This paper aims to review these core factors, such that providers new to CVT may offer teleprescribing services in a manner consistent with current clinical standards and regulatory requirements.

View Article and Find Full Text PDF

Attempts to synthesize solvent-free MgB12H12 by heating various solvated forms (H2O, NH3, and CH3OH) of the salt failed because of the competition between desolvation and dehydrogenation. This competition has been studied by thermogravimetric analysis (TGA) and temperature-programmed desorption (TPD). Products were characterized by IR, solution- and solid-state NMR spectroscopy, elemental analysis, and single-crystal or powder X-ray diffraction analysis.

View Article and Find Full Text PDF